HDAC9 interacts with a variety of transcriptional repressors and oncogenes (Ning et al., 2020) and may influence anticancer immune responses by limiting T-cell infiltration into the tumor microenvironment (TME) (Yang et al., 2021). The gene discussed is HDAC9; the disease is neoplasm.